9:00-10:30 |
Intro: Spadon, Read, Sussman, Riva di Sanseverino, Irwin Blundell |
Emerging threats Read Hilgenfeld |
Bioinformatics Sussman Thornton |
TB structural genomics Baker (30') Krajewski (20') Holton (20') Malaria Hora (20') |
Predictions Herzberg Moult |
10:30-11:00 |
coffee |
coffee |
coffee |
coffee |
coffee |
11:00-12:30 |
Crystals Bergfors Byrne |
Cryo Garman Membrane proteins Slattery (20') Solmaz (20') |
Radiation damage Garman Ravelli |
Experimental phasing Bricogne McCoy |
High throughput tools Adams Sheldrick |
12:30-2:30 |
lunch |
lunch |
lunch |
lunch |
lunch |
2:30-4:00 |
Data collection Dauter Leslie |
Kuhn Leslie (F1-ATPase) |
Dauter (halide soaks) Terwilliger (selecting foldable proteins) |
Excursion 1 Mothia Island (alternative, weather permitting, is San Vito lo Capo beach) |
Density improvement Turk (20') Emsley (25') Terwilliger |
4:00-4:30 |
tea |
tea |
tea |
tea |
|
4:30-6:30 |
demo |
demo |
Posters I |
demo |
9:00-10:30 |
Structures, biology & medicine Turk van Aalten |
Moult: SNPs Jaskolski: domain swapping |
New methods Schneider (40') Cohen (25') Vekhter (25') |
Crystallography in industry Pauptit (30') Lundqvist (30') Scapin (30') |
10:30-11:00 |
coffee |
coffee |
coffee |
coffee |
11:00-12:30 |
Sussman (20') Ultrahigh resolution Urzhumtsev Hakanpaa (20') |
Ab initio phasing Lunin Bricogne |
Refinement Murshudov Perrakis |
Difficult structures Berthold (30') Sevvana (30') Lott (30') |
12:30-2:30 |
lunch |
lunch |
lunch |
lunch |
2:30-4:00 |
Molecular replacement Glykos Read |
Excursion 2 Selinunte & Segesta (or San Vito lo Capo beach & Segesta) |
Hot topics TBA |
Future developments Hajdu Sayre |
4:00-4:30 |
tea |
tea |
tea |
|
4:30-6:30 |
demo |
Posters II |
concluding remarks |
9:00-10:30 |
Spadon, Read, Sussman, Riva di Sanseverino, Irwin |
Intro |
Blundell |
Fragment-based drug discovery |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Crystals |
|
Bergfors |
Crystallization |
|
Byrne |
Crystallizing membrane proteins |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Data collection |
|
Dauter |
Data collection strategy |
|
Leslie |
Processing diffraction data with Mosflm |
|
4:00-4:30 |
tea |
|
4:30-6:30 |
demo |
9:00-10:30 |
Emerging threats |
|
Read |
Designing responses to bacterial toxins |
|
Hilgenfeld |
Structural genomics and rapid responses to emerging threats |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Cryo techniques |
|
Garman |
Cryo-crystallography |
|
Membrane proteins |
||
Slattery (20') |
Designer lipids for membrane protein crystallogenesis |
|
Solmaz (20') |
Structure of Cytochrome bc1 complex from yeast with its substrate cytochrome c bound at 1.9Å resolution |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Kuhn |
In situ X-ray characterization using a microfluidic crystallization approach |
Leslie |
From snapshots to the big picture with F1-ATPase |
|
4:00-4:30 |
tea |
|
4:30-6:30 |
demo |
9:00-10:30 |
Bioinformatics |
|
Sussman |
Natively unfolded proteins |
|
Thornton |
Extracting and exploiting structural patterns |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Radiation damage |
|
Garman |
Understanding and limiting radiation damage |
|
Ravelli |
Exploiting radiation damage for RIP phasing |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Tools for phasing |
|
Dauter |
Phasing with halide soaks |
|
Terwilliger |
Selecting foldable proteins with GFP fusions |
|
4:00-4:30 |
tea |
|
4:30-6:30 |
Posters I with pizza party |
9:00-10:30 |
Structural genomics: TB |
|
Baker (30') |
The TB Structural Genomics project |
|
Krajewski (20') |
Targetting M. tb. glutamine synthetase |
|
Holton (20') |
Structural proteomics of M. tb. |
|
Malaria |
||
Hora (20') |
Structure-based insights into the function of Pfg27 |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Experimental phasing |
|
Bricogne |
Experimental phasing in SHARP |
|
McCoy |
Experimental phasing in Phaser |
|
12:30-2:30 |
lunch |
|
2:30-6:30 |
Excursion 1 |
9:00-10:30 |
Predictions |
|
Herzberg |
Predicting function from structure |
|
Moult |
CASP: how well can we predict structure? |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
High throughput tools |
|
Adams |
The PHENIX project |
|
Sheldrick |
High-throughput phasing with SHELX |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Density improvement |
|
Turk (20') |
Density modification in MAIN |
|
Emsley (25') |
Statistical density modification in Pirate |
|
Terwilliger |
Probabilistic density modification |
|
4:00-4:30 |
tea |
|
4:30-6:30 |
demo |
9:00-10:30 |
Structures, biology and medicine |
|
Turk |
Structure-based design of cathepsin inhibitors |
|
van Aalten |
Mechanism-based design of drug-like family 18 chitinase inhibitors |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Sussman (20') |
Lessons from acetylcholinesterase |
Ultrahigh resolution |
||
Urzhumtsev |
Macromolecules at a resolution beyond 1Å: maps and models |
|
Hakanpaa (20') |
From atomic to ultra high resolution: how high is high enough? |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Molecular replacement |
|
Glykos |
Stochastic molecular replacement |
|
Read |
Likelihood-based molecular replacement in Phaser |
|
4:00-4:30 |
tea |
|
4:30-6:30 |
demo |
9:00-10:30 |
Crystallography and inherited diseases |
|
Moult |
Modeling SNPs in human disease |
|
Jaskolski |
3D domain swapping and its relevance to conformational diseases |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Ab initio phasing |
|
Lunin |
Ab initio phasing starting from low resolution |
|
Bricogne |
Stereochemistry and ab initio phasing |
|
12:30-2:30 |
lunch |
|
2:30-6:30 |
Excursion 2 |
9:00-10:30 |
Contributions to new methods |
|
Schneider (40') |
Using genetic algorithms to identify domains and study conformational change |
|
Cohen (25') |
Software tools for automation in ARP/wARP |
|
Vekhter (25') |
Improving experimental phasing: the role of strongest reflections |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Refinement |
|
Murshudov |
Likelihood-based refinement in Refmac5 |
|
Perrakis |
Automated fitting and refinement with ARP/wARP |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Hot topics |
|
(to be chosen from participant abstracts) |
||
4:00-4:30 |
tea |
|
4:30-6:30 |
demo |
9:00-10:30 |
Crystallography in industry |
|
Pauptit (30') |
Is fragment-based screening an evolving method? |
|
Lundqvist (30') |
Protein flexibility: a curse or an opportunity in drug discovery? |
|
Scapin (30') |
Structural biology in drug discovery: from structures to mice and back |
|
10:30-11:00 |
coffee |
|
11:00-12:30 |
Difficult structures |
|
Berthold (30') |
Structure of oxalyl-CoA decarboxylase solved from a hemihedrally-twinned crystal |
|
Sevvana (30') |
Solving non-merohedrally twinned structures by anomalous scattering |
|
Lott (30') |
Making the most of two crystals |
|
12:30-2:30 |
lunch |
|
2:30-4:00 |
Future developments |
|
Hajdu |
Coupling crystallography and spectroscopy |
|
Sayre |
X-ray diffraction imaging of large single particles |
|
4:00-4:30 |
tea |
|
4:30-6:30 |
Concluding remarks |